2018 International Congress

Monday, October 8, 2018

1:15pm-2:45pm

Anti-glutamatergic effect of safinamide in Parkinson’s Disease: A TMS study

A. Guerra, A. Suppa, V. D'Onofrio, F. Di Stasio, F. Asci, G. Fabbrini, A. Berardelli (Rome, Italy)

Parkinson's Disease: Neuroimaging And Neurophysiology  ·  Hall 3FG

1:15pm-2:45pm

Antibodies to alpha-Synuclein in Parkinson disease

D. Labunskiy (Santa Rosa, CA, USA)

Parkinson's Disease: Pathophysiology  ·  Hall 3FG

1:15pm-2:45pm

Apathy in Parkinson’s disease is associated with abnormal alpha oscillatory behaviour during incentivized movement

M. Zhu, S. Garg, A. HajiHosseini, S. Appel-Cresswell, M. McKeown (Vancouver, BC, Canada)

Parkinson's Disease: Pathophysiology  ·  Hall 3FG

1:15pm-2:45pm

Apathy in Parkinson’s disease is associated with REM sleep behavior disorder

F. Ricordeau, M. Figorilli, A. Marques, T. Vidal, B. Beudin, B. Debilly, P. Derost, M. Puligheddu, F. Durif, M.L. Fantini (Clermont Ferrand, France)

Parkinson's Disease: Non-Motor Symptoms  ·  Hall 3FG

1:15pm-2:45pm

Apathy in rapid eye movement sleep behaviour disorder is associated with serotonin depletion in the raphe nuclei

T. Barber, L. Griffanti, K. Muhammed, D. Drew, K. Bradley, D. McGowan, M. Crabbe, C. Lo, C. Mackay, M. Husain, M. Hu, J. Klein (Oxford, United Kingdom)

Parkinson's Disease: Psychiatric Manifestations  ·  Hall 3FG

1:15pm-2:45pm

Application of the Movement Disorder Society Prodromal Criteria in healthy G2019S-LRRK2 carriers

A. Mirelman, R. Saunders-Pullman, R. Alcalay, S. Shustak, A. Thaler, B. Cohen, A. Hillel, T. Gurevich, D. Raymond, H. Mejia-Santana, L. Ozelius, L. Clark, M. Gana-Weisz, A. Bar-Shira, A. Orr-Urtreger, S. Bressman, K. Marder, N. Giladi (Tel Aviv, Israel)

Parkinson's Disease: Genetics  ·  Hall 3FG

1:15pm-2:45pm

Applying Intervention Mapping methodologies to enhance Data Completeness in Movement Disorders-related Scales

C. Goetz, S. Luo, G. Stebbins (Chicago, IL, USA)

Rating Scales  ·  Hall 3FG

1:15pm-2:45pm

Are the MDS-UPDRS-based composite scores clinically applicable?

N. Kovács, A. Juhász, Z. Aschermann (Pécs, Hungary)

Rating Scales  ·  Hall 3FG

1:15pm-2:45pm

Assessing hemifacial spasm: The HFSG scale

S. Simoni, N. Tambasco, E. Sacchini, E. Marsili, P. Nigro, E. Brahimi, M. Romoli, F. Paolini Paoletti, M. Filidei, P. Calabresi (Perugia, Italy)

Rating Scales  ·  Hall 3FG

1:15pm-2:45pm

Assessing the Quality of Economic Evaluation of Treatment Options for Parkinson’s disease Using the Quality of Health Economic Studies (QHES) Scale

M. Azharuddin, M. Adil, P. Ghosh, M. Sharma (New Delhi, India)

Rating Scales  ·  Hall 3FG